Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report
In the global context of the COVID-19 pandemic, the overall benefits of getting any COVID-19 vaccine approved by the World Health Organization for emergency use outweigh the potential risks, even in people with weakened immune systems, including people living with HIV (PLWH). At present, there are n...
Saved in:
Main Authors: | Guang Zeng (Author), Jie Tang (Author), Shuidong Feng (Author), Liumei Xu (Author), Xiaohui Wang (Author), Zhengrong Yang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inactivated COVID-19 vaccines, HBV and HIV: Correspondence
by: Pathum Sookaromdee, et al.
Published: (2022) -
Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial
by: Yamin Wang, et al.
Published: (2021) -
Should we vaccinate the better seroconverters or the most vulnerable? Game changing insights for COVID-19 vaccine prioritization policies
by: Antoine AbdelMassih, et al.
Published: (2021) -
Management of Vaccination Failure in a Case of HIV - HBV Co-infection: A Case Report
by: Andre Small, et al.
Published: (2014) -
Management of Vaccination Failure in a Case of HIV -HBV Co-infection: A Case Report
by: Andre Small, et al.
Published: (2014)